Abstract:Phosphodiesterase 10A (PDE10A) has been confirmed to be an important target for the treatment of central nervous system (CNS) disorders. The purpose of the present study was to identify PDE10A inhibitors from herbs used in traditional Chinese medicine. Pharmacophore and molecular docking techniques were used to virtually screen the chemical molecule database of Sophora flavescens, a well-known Chinese herb that has been used for improving mental health and regulating the CNS. The pharmacophore model generated recognized the common functional groups of known PDE10A inhibitors. In addition, molecular docking was used to calculate the binding affinity of ligand‐PDE10A interactions and to investigate the possible binding pattern. Virtual screening based on the pharmacophore model and molecular docking was performed to identify potential PDE10A inhibitors from S. flavescens. The results demonstrated that nine hits from S. flavescens were potential PDE10A inhibitors, and their biological activity was further validated using literature mining. A total of two compounds were reported to inhibit cyclic adenosine monophosphate phosphodiesterase, and one protected against glutamate-induced oxidative stress in the CNS. The remaining six compounds require further bioactivity validation. The results of the present study demonstrated that this method was a timeand cost-saving strategy for the identification of bioactive compounds from traditional Chinese medicine. Introduction Phosphodiesterases (PDEs) are a family of enzymes that are able to lyse phosphodiester bonds, are expressed widely, and have demonstrable clinical significance (1,2). PDE10A has been demonstrated to be a potential target for the treatment of central nervous system (CNS) disorders (3,4). Previous studies have confirmed that PDE10A inhibitors have important biological activity in the treatment of psychosis (5-7). Therefore, screening for PDE10A inhibitors is an effective strategy for the treatment of CNS disorders. The roots of Sophora flavescens (Sophorae radix) have been used as an herbal medicine for thousands of years in East Asian countries. They have been demonstrated to possess diverse pharmacological properties, including antitumor, antioxidant, anti-inflammatory, antiapoptotic, vasodilatory and CNS regulatory functions (8-15). Different types of compounds, including triterpenoids, flavonoids and quinolizidine alkaloids, have been isolated from the roots of S. flavescens (16-19). In order to identify natural PDE10A inhibitors, virtual screening based on a pharmacophore model and molecular docking was performed to identify the chemical molecule database of S. flavescens. In addition, literature mining was performed to validate the biological activity of the top-ranking hits from the virtual screening. A total of two hits were reported to have inhibitory activity against cyclic adenosine monophosphate (cAMP) phosphodiesterase, while one exhibited protective effects against glutamate-induced oxidative stress in the CNS. The computational methods used in the present study efficiently identified PDE10A inhibitors from the roots of S. flavescens. Therefore, this screening method and workflow may be applied to other traditional Chinese medicines in the search for potential bioactive compounds. Materials and methods Chemical molecule database of S. flavescens. In order to establish the chemical molecule database of S. flavescens, the traditional Chinese medicine database (Chinese Academy The rational search for PDE10A inhibitors from Sophora flavescens roots using pharmacophore‐ and docking‐based virtual screening HAN-TIAN FAN1, JUN-FANG GUO1, YU-XIN ZHANG2, YU-XI GU1, ZHONG-QI NING1, YAN-JIANG QIAO2 and XING WANG1,3 1School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069; 2Key Laboratory of TCM-Information Engineer of State Administration of TCM, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102; 3Beijing Key Laboratory of Traditional Chinese Medicine (TCM) Collateral Disease Theory Research, Capital Medical University, Beijing 100069, P.R. China Received May 27, 2017; Accepted August 31, 2017 DOI: 10.3892/mmr.2017.7871 Correspondence to: Dr Xing Wang, Beijing Key Laboratory of Traditional Chinese Medicine (TCM) Collateral Disease Theory Research, Capital Medical University, 10 Youanmen Road, Xitoutiao, Beijing 100069, P.R. China E-mail: kingstar1016@sina.com

The Rational Search for PDE10A Inhibitors from Sophoraï¿½flavescens Roots Using Pharmacophore‑ and Docking‑based Virtual Screening

The rational search for PDE10A inhibitors from Sophora flavescens roots using pharmacophore‑ and docking‑based virtual screening.

The rational search for PDE 10 A inhibitors from Sophora flavescens roots using pharmacophore ‐ and docking ‐ based virtual screening

Natural Product Virtual-Interact-Phenotypic Target Characterization: A Novel Approach Demonstrated with Salvia Miltiorrhiza Extract

Structure-Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel PDE10 Inhibitors with Antioxidant Activities

Identification of Novel Phosphodiesterase-4D Inhibitors Prescreened by Molecular Dynamics-Augmented Modeling and Validated by Bioassay.

Pharmacological Targets Identification and Efficacy Analysis of Phenylethanoid Glycosides from Cistanches Herba Based on "target Fishing" Strategy

Screening of peptidyl arginine deiminase 4 inhibitors in traditional herbal medicines

Inhibition mechanism exploration of quinoline derivatives as PDE10A inhibitors by in silico analysis

Drug Discovery of Neurodegenerative Disease Through Network Pharmacology Approach in Herbs

Key Features for Designing Phosphodiesterase-5 Inhibitors.

[Virtual Screening of Anti-Angiogenesis Flavonoids from Sophora Flavescens].

Discovery of Novel PDE10 Inhibitors by a Robust Homogeneous Screening Assay.

Discovery and Optimization of Chromone Derivatives as Novel Selective Phosphodiesterase 10 Inhibitors.

Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds.

A Systematic Strategy for Screening Therapeutic Constituents of Schisandra Chinensis (turcz.) Baill Infiltrated Blood–brain Barrier Oriented in Lesions Using Ethanol and Water Extracts: a Novel Perspective for Exploring Chemical Material Basis of Herb Medicines

Discovery of Potent Inhibitors for Phosphodiesterase 5 by Virtual Screening and Pharmacophore Analysis

Uncovering Potential Anti-Neuroinflammatory Components of Modified Wuziyanzong Prescription Through a Target-Directed Molecular Docking Fingerprint Strategy.

Integration of Multiple Analytical and Computational Tools for the Discovery of High-Potency Enzyme Inhibitors from Herbal Medicines.

Rapid screening and identification of superoxide dismutase activators from traditional Chinese medicines based on affinity ultrafiltration mass chromatography combined with molecular docking

A NMR-based drug screening strategy for discovering active substances from herbal medicines: Using Radix Polygoni Multiflori as example